AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23150927
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 mcg)
Trial: 15163329
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg PTU
Trial: 10369190
Drug: Prednisone or
RxNorm normalized name: prednisone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone or prednisolone at 60 mg/m2 per day (up to 80 mg/day) for four to six weeks, followed by 40 mg/m2 every other day for another four to six weeks
Trial: 10369190
Drug: Prednisone at
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone at 60 mg/m2/day (up to 80 mg/day) until urine is protein free for three days, then 40 mg/m2 every other day for another month
Trial: 7996346
Drug: Intravenously administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenously administered immune globulin, 0.5 gm/kg per day for 5 consecutive days (n = 19)
Trial: 28318138
Drug: 6-month dual
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month dual antiplatelet therapy (DAPT)
Trial: 8635703
Drug: Injection therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection therapy (adrenaline and polidocanol)
Trial: 18946626
Drug: Neridronate 25
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neridronate 25 mg IM every 2 weeks
Trial: 18946626
Drug: Neridronate 25
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neridronate 25 mg IM every 4 weeks
Trial: 30088663
Drug: ACT-246475 32
RxNorm normalized name: ACT-246475
DrugBank: Selatogrel (DB15163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT-246475 32 mg
Trial: 30989330
Drug: Imatinib 400
RxNorm normalized name: imatinib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib 400 mg once daily
Trial: 16270637
Drug: Ximelagatran 24
RxNorm normalized name: Ximelagatrán
DrugBank: Ximelagatran (DB04898)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ximelagatran 24 mg twice daily
Trial: 8201222
Drug: Interferon therapy
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon therapy (alone)
Trial: 9577904
Drug: Erythromycin 50
RxNorm normalized name: erythromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 50 mg i.v.
Trial: 9577904
Drug: Erythromycin 500
RxNorm normalized name: erythromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 500 mg i.v.
Trial: 345489
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of LH-RH
Trial: 26853211
Drug: Indigenous Oral
RxNorm normalized name: Indigenous peanut oil
DrugBank: Peanut oil (DB13964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indigenous Oral Health Literacy Project (IOHLP) participants
Trial: 29570467
Drug: Bedside respiratory
RxNorm normalized name: Bedside-Care
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bedside respiratory muscle training (twice a day for 3 weeks) including breath stacking exercise, inspiratory muscle training, and expiratory muscle training.
Trial: 12222753
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of metformin with placebo
Trial: 12416945
Drug: Cardioselective β-blocker
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cardioselective β-blocker (single dose)
Trial: 16088265
Drug: Mind-body therapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mind-body therapy
Trial: 12017349
Drug: Verteporfin 3
RxNorm normalized name: Verteporfin
DrugBank: Verteporfin (DB00460)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Verteporfin 3 to 20 mg/m2 of body surface area infused over 1.5 to 45 minutes
Trial: 134722
Drug: Ipratropiumbromide by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipratropiumbromide by i.v. injection (max dose 0.28 mg)
Trial: 15298643
Drug: Micafungin 75
RxNorm normalized name: Micafungin
DrugBank: Micafungin (DB01141)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Micafungin 75 mg
Trial: 17448371
Drug: Rosiglitazone (RSG)
DrugBank: Rosiglitazone (DB00412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (RSG) 4 to 8 mg daily (n = 110)
Trial: 30817466
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment of SBP to less than 120 mmHg (SPRINT)
Trial: 30817466
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment of SBP to less than 120 mmHg (THIN)
Trial: 15238279
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg copper/L
Trial: 25048824
Drug: Insulin detemir
RxNorm normalized name: Insulin Detemir
DrugBank: Insulin detemir (DB01307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin detemir (IDet)
Trial: 8969280
Drug: Diet P
RxNorm normalized name: T-Diet Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet P (32 g protein/d)
Trial: 8969280
Drug: Diet M
RxNorm normalized name: Coenzyme M
DrugBank: Coenzyme M (DB09110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet M (10 mmol L-methionine/d)
Trial: 24521771
Drug: tacrolimus extended-release
RxNorm normalized name: tacrolimus Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tacrolimus extended-release (Astagraf XL)
Trial: 15842142
Drug: Prednisone 30
RxNorm normalized name: prednisone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 30 mg, once a day
Trial: 30295335
Drug: Crizanlizumab 5
RxNorm normalized name: Crizanlizumab
DrugBank: Crizanlizumab (DB15271)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Crizanlizumab 5 mg/kg
Trial: 25131223
Drug: Biologics-treated groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biologics-treated groups (RhCTLA4-Ig and infliximab combined)
Trial: 21148531
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated influenza vaccine (TIV)
Trial: 10536064
Drug: Twice-daily administration
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily administration of budesonide (200-400 microg/day)
Trial: 2150533
Drug: Untreated hypertensives
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Untreated hypertensives with randomly allocated treatment
Trial: 9126802
Drug: Silymarin 600
RxNorm normalized name: silymarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin 600 mg per day
Trial: 19552488
Drug: Blonanserin 10
RxNorm normalized name: Blonanserin
DrugBank: Blonanserin (DB09223)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Blonanserin 10 mg
Trial: 21552707
Drug: Enzymatic solution
RxNorm normalized name: hydrolyzed sericin (enzymatic; 2500 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzymatic solution
Trial: 19856793
Drug: Isoxsuprine hydrochloride
RxNorm normalized name: Isoxsuprine Hydrochloride
DrugBank: Isoxsuprine (DB08941)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoxsuprine hydrochloride 30 mg
Trial: 19856793
Drug: Isoxsuprine hydrochloride
RxNorm normalized name: Isoxsuprine Hydrochloride
DrugBank: Isoxsuprine (DB08941)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoxsuprine hydrochloride 60 mg
Trial: 9469531
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 1 mg/ml morphine and 3 mg/ml ketorolac
Trial: 8203838
Drug: ofloxacin plus
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ofloxacin plus roxithromycin (150 mg twice daily)
Trial: 22404250
Drug: Two-step technique
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Two-step technique (first treating only reticular veins with a single injection at the base of each cluster of telangiectasias, then successively injecting all remaining telangiectasias a few minutes later)
Trial: 3501750
Drug: Ofloxacin 100mg
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin 100mg twice daily for 3 days
Trial: 8749149
Drug: Loratadine 10
RxNorm normalized name: loratadine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine 10 mg daily
Trial: 17496674
Drug: Neuromonics Tinnitus
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromonics Tinnitus Treatment (first variation)
Trial: 17496674
Drug: Neuromonics Tinnitus
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromonics Tinnitus Treatment (second variation)
Trial: 31308344
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with HDM 300 IR tablets for 52 weeks
Trial: 3535552
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose piperacillin
Trial: 18613992
Drug: Alternative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative treatment group (lifestyle changes, red yeast rice, and fish oil)
Trial: 10713867
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Remifentanil and Propofol (group RP)
Trial: 2379228
Drug: Cloxacillin 500
RxNorm normalized name: cloxacillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cloxacillin 500 mg orally thrice daily for seven days
Trial: 3880879
Drug: Dexamethasone therapy
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone therapy
Trial: 17531887
Drug: Low-dose NaFeEDTA
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose NaFeEDTA (28 mg/kg)
Trial: 17531887
Drug: Electrolytic iron
RxNorm normalized name: electrolytic iron
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electrolytic iron (56 mg/kg)
Trial: 10677394
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of high dose (250 mg/250 mg) of lactulose/rhamnose
Trial: 30958879
Drug: Activity impairment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activity impairment improvement with acute-phase treatment in STAR∗D (F = 7.27; df = 2,2625; P <. 001)
Trial: 2675434
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg nitrazepam
Trial: 19542901
Drug: Alglucosidase alpha
RxNorm normalized name: Alglucosidase alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alglucosidase alpha 20 mg/kg biweekly
Trial: 15023154
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir 1000 mg three times a day
Trial: 8281693
Drug: Ethinyl estradiol
RxNorm normalized name: Ethinyl Estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ethinyl estradiol (EE), 35 micrograms, intravenous administration
Trial: 19185645
Drug: Anacetrapib 10
RxNorm normalized name: Anacetrapib
DrugBank: Anacetrapib (DB06630)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anacetrapib 10 mg once daily for 8 weeks
Trial: 19185645
Drug: Anacetrapib 40
RxNorm normalized name: Anacetrapib
DrugBank: Anacetrapib (DB06630)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anacetrapib 40 mg once daily for 8 weeks
Trial: 6476586
Drug: 2.0 mg
RxNorm normalized name: LORAZEPAM 2.0 mg in 1 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg atropine sulfate
Trial: 15230341
Drug: Cefaclor extended
RxNorm normalized name: Cefaclor Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor extended release 500‐mg tablet after low‐fat vegetarian diet
Trial: 15230341
Drug: Cefaclor extended
RxNorm normalized name: Cefaclor Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor extended release 500‐mg tablet after high‐fat non-vegetarian diet
Trial: 3291657
Drug: Radiation followed
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiation followed by 6 cycles of MOPP chemotherapy (159 patients)
Trial: 22535269
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (perindopril +/‐ indapamide)
Trial: 3773181
Drug: Drug information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug information sheet
Trial: 10206320
Drug: Azimilide 35
RxNorm normalized name: Azimilide
DrugBank: Azimilide (DB04957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide 35 mg day(-1)
Trial: 22548394
Drug: Flumetasone ointment
RxNorm normalized name: flumetasone
DrugBank: Flumethasone (DB00663)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumetasone ointment plus 308-nm excimer laser therapy
Trial: 22017520
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg/day
Trial: 12040291
Drug: G-CSF administration
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF administration at 7:00 am
Trial: 12040291
Drug: G-CSF administration
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF administration at 7:00 pm
Trial: 27143319
Drug: Optimal medical
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal medical therapy (control group)
Trial: 27143319
Drug: Renal denervation
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renal denervation (RDN) plus optimal medical therapy
Trial: 3877303
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion for maintenance of anaesthesia
Trial: 2887153
Drug: Topical 1%
RxNorm normalized name: fluoride topical 1% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 1% ALO 2145
Trial: 20731494
Drug: Infant Health
RxNorm normalized name: MENS HEALTH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infant Health and Development Program treatment group
Trial: 11426360
Drug: Intravenous milrinone
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous milrinone
Trial: 26403206
Drug: Preoperative ultrasound-guided
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative ultrasound-guided femoral nerve block (FNB) with 20 mL of 0.5% bupivacaine
Trial: 18303408
Drug: FPDNA levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FPDNA levels above cutoff after chemotherapy
Trial: 16842390
Drug: Fexofenadine 120
RxNorm normalized name: fexofenadine hydrochloride 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine 120 mg
Trial: 31331968
Drug: Dalfampridine 10
RxNorm normalized name: dalfampridine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalfampridine 10 mg twice daily for 12 weeks
Trial: 23018816
Drug: Periodontal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodontal treatment
Trial: 12747273
Drug: Diclofenac hydroxyethylpyrrolidine
RxNorm normalized name: diclofenac hydroxyethylpyrrolidine 1.292 % Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac hydroxyethylpyrrolidine (DHEP) patch
Trial: 11673813
Drug: Remune monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remune monotherapy (administered every 12 weeks)
Trial: 12504657
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (MMC) 10 mg/m2 on day 1 and continuous infusion of 5-fluorouracil (5-FU) 200 mg/m2
Trial: 7786531
Drug: Propafenone 300
RxNorm normalized name: propafenone 300 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 300 mg twice daily
Trial: 15570084
Drug: Tipifarnib 600
RxNorm normalized name: Tipifarnib
DrugBank: Tipifarnib (DB04960)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tipifarnib 600 mg bid
Trial: 15963197
Drug: Sibutramine 15
RxNorm normalized name: sibutramine 15 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 15 mg once daily for 12 weeks
Trial: 29203355
Drug: drisapersen 6
RxNorm normalized name: drisapersen
DrugBank: Drisapersen (DB13688)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: drisapersen 6 mg/kg/week
Trial: 17286569
Drug: ATP injection
RxNorm normalized name: ATP
DrugBank: ATP (DB00171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATP injection during intravenous isoproterenol infusion (ISP-infusion) after successful extensive encircling pulmonary vein isolation (EEPVI)
Trial: 17286569
Drug: ATP injection
RxNorm normalized name: ATP
DrugBank: ATP (DB00171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATP injection
Trial: 8605125
Drug: Amniotomy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amniotomy followed by oxytocin infusion after 1 h (group A, n = 98)
Trial: 7094971
Drug: Clomipramine (C1)
RxNorm normalized name: C1-INH
DrugBank: Clomipramine (DB01242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomipramine (C1) at 75 mg per day
Trial: 28394665
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ablative ultrapulse CO2 followed by fixed-dose QS Nd:YAG laser (1064 nm)
Trial: 31175814
Drug: Active Music
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Music Therapy (MT)
Trial: 14573318
Drug: Antidepressant-free patients
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant-free patients
Trial: 26529159
Drug: efavirenz-based therapy
RxNorm normalized name: Efavirenz
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: efavirenz-based therapy
Trial: 26529159
Drug: ritonavir-boosted lopinavir-based
RxNorm normalized name: lopinavir / ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ritonavir-boosted lopinavir-based therapy
Trial: 10599373
Drug: Betamethasone propionate
RxNorm normalized name: calcipotriene 0.005 % / betamethasone propionate 0.064 % Topical Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone propionate cream alone
Trial: 8698947
Drug: Cognitive-behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavior therapy
Trial: 2018160
Drug: Cognitive-behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavior therapy with buspirone
Trial: 2018160
Drug: Cognitive-behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavior therapy with placebo
Trial: 14755152
Drug: Herbal preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal preparation STW 5‐II
Trial: 8659218
Drug: Postoperative low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative low molecular weight heparin (tinzaparin)
Trial: 17067720
Drug: Intranasal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal fentanyl (150 microg/mL)
Trial: 12566476
Drug: CHO Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO Group (Carbohydrate Group) consuming a diet with a CHO/protein ratio of 3.5 (68 g protein/d)
Trial: 21180275
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (routine Ringer's solution)
Trial: 9398894
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg + Metronidazole 400 mg + Clarithromycin 250 mg (OMC250)